Alexander J, Schipper K, Nash S, Brough R, et al. Pathway-based signatures predict patient outcome, chemotherapy benefit and synthetic lethal dependencies in invasive lobular breast cancer. Br J Cancer 2024 Apr 10. doi: 10.1038/s41416-024-02679.
PMID: 38600325